| - GRCh37:
- Chr12:121416289
- GRCh38:
- Chr12:120978486
| HNF1A | | Monogenic diabetes | Likely pathogenic (Aug 18, 2021) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr12:121416447
- GRCh38:
- Chr12:120978644
| HNF1A | | Maturity-onset diabetes of the young type 3 | Pathogenic (Jan 1, 2000) | no assertion criteria provided |
| - GRCh37:
- Chr12:121416572
- GRCh38:
- Chr12:120978769
| HNF1A | M1L | Monogenic diabetes | Likely pathogenic (Mar 4, 2022) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr12:121416572
- GRCh38:
- Chr12:120978769
| HNF1A | M1L | Monogenic diabetes | Pathogenic (Mar 4, 2022) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr12:121416572
- GRCh38:
- Chr12:120978769
| HNF1A | M1V | Monogenic diabetes | Pathogenic (Mar 4, 2022) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr12:121416573
- GRCh38:
- Chr12:120978770
| HNF1A | M1T | Monogenic diabetes | Pathogenic (Aug 26, 2022) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr12:121416574
- GRCh38:
- Chr12:120978771
| HNF1A | V2fs | Monogenic diabetes | Pathogenic (Feb 22, 2022) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr12:121416587
- GRCh38:
- Chr12:120978784
| HNF1A | S6C | Monogenic diabetes | Likely pathogenic (Mar 4, 2022) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr12:121416588
- GRCh38:
- Chr12:120978785
| HNF1A | S6N | Monogenic diabetes | Likely pathogenic (Mar 4, 2022) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr12:121416590-121416591
- GRCh38:
- Chr12:120978787-120978788
| HNF1A | | Monogenic diabetes | Likely pathogenic (Mar 25, 2022) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr12:121416590
- GRCh38:
- Chr12:120978787
| HNF1A | Q7* | Monogenic diabetes | Pathogenic (Mar 18, 2022) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr12:121416596
- GRCh38:
- Chr12:120978793
| HNF1A | Q9* | Monogenic diabetes | Pathogenic (Mar 25, 2022) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr12:121416597
- GRCh38:
- Chr12:120978794
| HNF1A | Q9L | Maturity-onset diabetes of the young type 3 | Likely pathogenic | criteria provided, single submitter |
| - GRCh37:
- Chr12:121416599
- GRCh38:
- Chr12:120978796
| HNF1A | T10P | Monogenic diabetes | Likely pathogenic (Mar 25, 2022) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr12:121416605
- GRCh38:
- Chr12:120978802
| HNF1A | L12F | Monogenic diabetes | Likely pathogenic (Mar 25, 2022) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr12:121416605
- GRCh38:
- Chr12:120978802
| HNF1A | L12V | Monogenic diabetes | Likely pathogenic (Mar 25, 2022) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr12:121416606
- GRCh38:
- Chr12:120978803
| HNF1A | L12R | Monogenic diabetes | Likely pathogenic (Mar 30, 2022) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr12:121416613-121416622
- GRCh38:
- Chr12:120978810-120978819
| HNF1A | A15fs | Monogenic diabetes | Pathogenic (Mar 31, 2022) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr12:121416623
- GRCh38:
- Chr12:120978820
| HNF1A | E18* | Maturity onset diabetes mellitus in young, Maturity-onset diabetes of the young type 3 | Pathogenic/Likely pathogenic (Aug 2, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:121416629
- GRCh38:
- Chr12:120978826
| HNF1A | G20R | Monogenic diabetes | Likely pathogenic (Aug 18, 2021) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr12:121416629
- GRCh38:
- Chr12:120978826
| HNF1A | G20R | Monogenic diabetes | Pathogenic (Aug 18, 2021) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr12:121416630
- GRCh38:
- Chr12:120978827
| HNF1A | G20E | Monogenic diabetes | Likely pathogenic (Aug 18, 2021) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr12:121416630
- GRCh38:
- Chr12:120978827
| HNF1A | G20A | Monogenic diabetes | Likely pathogenic (Aug 18, 2021) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr12:121416630
- GRCh38:
- Chr12:120978827
| HNF1A | G20V | not provided | Likely pathogenic (Sep 16, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr12:121416640-121416641
- GRCh38:
- Chr12:120978837-120978838
| HNF1A | E24fs | Monogenic diabetes | Pathogenic (Apr 1, 2022) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr12:121416648
- GRCh38:
- Chr12:120978845
| HNF1A | L26P | Monogenic diabetes | Likely pathogenic (Apr 2, 2022) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr12:121416653
- GRCh38:
- Chr12:120978850
| HNF1A | Q28* | Monogenic diabetes | Likely pathogenic (Feb 8, 2022) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr12:121416665
- GRCh38:
- Chr12:120978862
| HNF1A | E32* | Monogenic diabetes | Pathogenic (Apr 2, 2022) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr12:121416669
- GRCh38:
- Chr12:120978866
| HNF1A | P33L | Monogenic diabetes | Likely pathogenic (Apr 2, 2022) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr12:121416676-121416686
- GRCh38:
- Chr12:120978873-120978883
| HNF1A | Y36fs | not provided | Pathogenic (Apr 18, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr12:121416692
- GRCh38:
- Chr12:120978889
| HNF1A | E41* | Monogenic diabetes | Pathogenic (Apr 2, 2022) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr12:121416697
- GRCh38:
- Chr12:120978894
| HNF1A | L44fs | Monogenic diabetes | Pathogenic (Apr 2, 2022) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr12:121416700-121416701
- GRCh38:
- Chr12:120978897-120978898
| HNF1A | L44fs | Monogenic diabetes | Pathogenic (May 4, 2022) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr12:121416709-121416725
- GRCh38:
- Chr12:120978906-120978922
| HNF1A | G47fs | Maturity onset diabetes mellitus in young | Likely pathogenic (Mar 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:121416709
- GRCh38:
- Chr12:120978906
| HNF1A | E48fs | Monogenic diabetes | Pathogenic (Apr 2, 2022) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr12:121416717
- GRCh38:
- Chr12:120978914
| HNF1A | S49Y | not provided | Likely pathogenic (Dec 9, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr12:121416721
- GRCh38:
- Chr12:120978918
| HNF1A | C50* | Maturity onset diabetes mellitus in young | Pathogenic (Mar 3, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr12:121416731
- GRCh38:
- Chr12:120978928
| HNF1A | R54G | Maturity onset diabetes mellitus in young | Pathogenic | criteria provided, single submitter |
| - GRCh37:
- Chr12:121416731
- GRCh38:
- Chr12:120978928
| HNF1A | R54* | Monogenic diabetes | Pathogenic (Dec 28, 2021) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr12:121416732-121416736
- GRCh38:
- Chr12:120978929-120978933
| HNF1A | G55fs | Monogenic diabetes | Pathogenic (Apr 2, 2022) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr12:121416740
- GRCh38:
- Chr12:120978937
| HNF1A | L57fs | Monogenic diabetes | Likely pathogenic (Apr 3, 2022) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr12:121416755
- GRCh38:
- Chr12:120978952
| HNF1A | N62fs | Monogenic diabetes | Pathogenic (Apr 3, 2022) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr12:121416757
- GRCh38:
- Chr12:120978954
| HNF1A | N62fs | Monogenic diabetes | Likely pathogenic (Apr 3, 2022) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr12:121416762-121416763
- GRCh38:
- Chr12:120978959-120978960
| HNF1A | E66fs | Monogenic diabetes | Pathogenic (Apr 3, 2022) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr12:121416774
- GRCh38:
- Chr12:120978971
| HNF1A | G69fs | Monogenic diabetes | Likely pathogenic (Apr 4, 2022) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr12:121416782
- GRCh38:
- Chr12:120978979
| HNF1A | E71* | not provided | Pathogenic (Mar 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:121416788
- GRCh38:
- Chr12:120978985
| HNF1A | E73* | Monogenic diabetes | Likely pathogenic (Apr 4, 2022) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr12:121416830
- GRCh38:
- Chr12:120979027
| HNF1A | K87* | Monogenic diabetes | Likely pathogenic (Apr 6, 2022) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr12:121416833
- GRCh38:
- Chr12:120979030
| HNF1A | E88* | not provided | Pathogenic (Oct 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:121416852-121416853
- GRCh38:
- Chr12:120979049-120979050
| HNF1A | E95* | Monogenic diabetes | Likely pathogenic (Apr 7, 2022) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr12:121416882-121416883
- GRCh38:
- Chr12:120979079-120979080
| HNF1A | E105fs | Monogenic diabetes | Likely pathogenic (Apr 7, 2022) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr12:121416890
- GRCh38:
- Chr12:120979087
| HNF1A | L107I | Monogenic diabetes | Likely pathogenic (Aug 19, 2021) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr12:121416891
- GRCh38:
- Chr12:120979088
| HNF1A | L107P | Monogenic diabetes | Likely pathogenic (Sep 15, 2021) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr12:121416891
- GRCh38:
- Chr12:120979088
| HNF1A | L107R | Monogenic diabetes | Likely pathogenic (Sep 15, 2021) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr12:121416898
- GRCh38:
- Chr12:120979095
| HNF1A | | Monogenic diabetes | Pathogenic (Jun 10, 2022) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr12:121416898
- GRCh38:
- Chr12:120979095
| HNF1A | | Monogenic diabetes | Pathogenic (Jun 10, 2022) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr12:121416898
- GRCh38:
- Chr12:120979095
| HNF1A | | Monogenic diabetes | Pathogenic (Jun 10, 2022) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr12:121416899
- GRCh38:
- Chr12:120979096
| HNF1A | | Monogenic diabetes | Likely pathogenic (Apr 7, 2022) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr12:121426633-121426635
- GRCh38:
- Chr12:120988830-120988832
| HNF1A | | Maturity onset diabetes mellitus in young, not provided | Pathogenic/Likely pathogenic (Oct 17, 2019) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:121426634
- GRCh38:
- Chr12:120988831
| HNF1A | | Monogenic diabetes | Likely pathogenic (Apr 17, 2022) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr12:121426635
- GRCh38:
- Chr12:120988832
| HNF1A | | Monogenic diabetes | Pathogenic (Aug 5, 2022) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr12:121426635
- GRCh38:
- Chr12:120988832
| HNF1A | | Monogenic diabetes | Pathogenic (Apr 18, 2022) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr12:121426644
- GRCh38:
- Chr12:120988841
| HNF1A | P112L | Monogenic diabetes | Pathogenic (Apr 8, 2022) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr12:121426647
- GRCh38:
- Chr12:120988844
| HNF1A | W113* | Maturity onset diabetes mellitus in young | Pathogenic | criteria provided, single submitter |
| - GRCh37:
- Chr12:121426650-121426651
- GRCh38:
- Chr12:120988847-120988848
| HNF1A | V115fs | Monogenic diabetes | Likely pathogenic (Feb 8, 2022) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr12:121426656
- GRCh38:
- Chr12:120988853
| HNF1A | A116V | Maturity-onset diabetes of the young type 3 | Pathogenic (Aug 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:121426674
- GRCh38:
- Chr12:120988871
| HNF1A | Y122C | Monogenic diabetes | Likely pathogenic (Aug 19, 2021) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr12:121426675
- GRCh38:
- Chr12:120988872
| HNF1A | Y122* | not provided | Pathogenic (Nov 4, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr12:121426677-121426678
- GRCh38:
- Chr12:120988874-120988875
| HNF1A | | Monogenic diabetes | Likely pathogenic (Apr 10, 2022) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr12:121426679
- GRCh38:
- Chr12:120988876
| HNF1A | Q124* | Maturity onset diabetes mellitus in young, not provided | Pathogenic (May 4, 2018) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:121426686
- GRCh38:
- Chr12:120988883
| HNF1A | H126R | not provided | Pathogenic (Mar 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:121426686-121426688
- GRCh38:
- Chr12:120988883-120988885
| HNF1A | N127del | Monogenic diabetes | Likely pathogenic (Jun 15, 2022) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr12:121426697
- GRCh38:
- Chr12:120988894
| HNF1A | Q130* | Maturity onset diabetes mellitus in young, not provided | Pathogenic (Sep 17, 2019) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:121426700
- GRCh38:
- Chr12:120988897
| HNF1A | R131W | Monogenic diabetes | Pathogenic (Aug 18, 2021) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr12:121426701
- GRCh38:
- Chr12:120988898
| HNF1A | R131Q | Monogenic diabetes | Pathogenic (Aug 11, 2021) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr12:121426701
- GRCh38:
- Chr12:120988898
| HNF1A | R131L | Monogenic diabetes | Likely pathogenic (Aug 18, 2021) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr12:121426706
- GRCh38:
- Chr12:120988903
| HNF1A | V133M | Monogenic diabetes | Likely pathogenic (Jun 24, 2022) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr12:121426707-121426713
- GRCh38:
- Chr12:120988904-120988910
| HNF1A | V134fs | Monogenic diabetes | Likely pathogenic (Jun 24, 2022) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr12:121426713
- GRCh38:
- Chr12:120988910
| HNF1A | D135fs | Monogenic diabetes | Pathogenic (Jul 1, 2022) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr12:121426713
- GRCh38:
- Chr12:120988910
| HNF1A | D135A | Maturity onset diabetes mellitus in young | Likely pathogenic | criteria provided, single submitter |
| - GRCh37:
- Chr12:121426725
- GRCh38:
- Chr12:120988922
| HNF1A | L139P | not provided | Likely pathogenic (May 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:121426734
- GRCh38:
- Chr12:120988931
| HNF1A | S142F | Monogenic diabetes | Pathogenic (Aug 24, 2021) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr12:121426734
- GRCh38:
- Chr12:120988931
| HNF1A | H143fs | Monogenic diabetes | Likely pathogenic (Oct 29, 2021) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr12:121426736
- GRCh38:
- Chr12:120988933
| HNF1A | H143Y | Monogenic diabetes | Pathogenic (Aug 24, 2021) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr12:121426738
- GRCh38:
- Chr12:120988935
| HNF1A | H143Q | Monogenic diabetes | Likely pathogenic (Nov 3, 2021) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr12:121426740
- GRCh38:
- Chr12:120988937
| HNF1A | L144R | not provided | Likely pathogenic (Apr 24, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr12:121426743
- GRCh38:
- Chr12:120988940
| HNF1A | S145F | Monogenic diabetes | Pathogenic (Apr 8, 2022) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr12:121426759
- GRCh38:
- Chr12:120988956
| HNF1A | G151fs | not provided | Pathogenic (Aug 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:121426776
- GRCh38:
- Chr12:120988973
| HNF1A | T156K | Maturity-onset diabetes of the young type 3 | Likely pathogenic (May 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr12:121426781
- GRCh38:
- Chr12:120988978
| HNF1A | K158* | not provided | Pathogenic (Oct 26, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr12:121426784
- GRCh38:
- Chr12:120988981
| HNF1A | R159G | Monogenic diabetes | Likely pathogenic (Apr 9, 2022) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr12:121426784
- GRCh38:
- Chr12:120988981
| HNF1A | R159W | Monogenic diabetes | Pathogenic (Dec 22, 2021) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr12:121426785
- GRCh38:
- Chr12:120988982
| HNF1A | A160fs | Maturity onset diabetes mellitus in young | Pathogenic (Feb 4, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr12:121426785
- GRCh38:
- Chr12:120988982
| HNF1A | R159Q | Monogenic diabetes | Pathogenic (Dec 30, 2021) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr12:121426803
- GRCh38:
- Chr12:120989000
| HNF1A | W165* | Monogenic diabetes | Pathogenic (Jun 10, 2022) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr12:121426820
- GRCh38:
- Chr12:120989017
| HNF1A | R171G | not provided, Maturity onset diabetes mellitus in young | Pathogenic (Oct 13, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:121426820
- GRCh38:
- Chr12:120989017
| HNF1A | R171* | Monogenic diabetes | Pathogenic (Apr 10, 2022) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr12:121426823-121426868
- GRCh38:
- Chr12:120989020-120989065
| HNF1A | | Monogenic diabetes | Likely pathogenic (Apr 20, 2022) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr12:121426835
- GRCh38:
- Chr12:120989032
| HNF1A | Q176* | Monogenic diabetes | Pathogenic (Apr 10, 2022) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr12:121426836
- GRCh38:
- Chr12:120989033
| HNF1A | | Maturity onset diabetes mellitus in young | Pathogenic (Jun 18, 2018) | criteria provided, single submitter |